Related Experiment Videos
[Ceruloplasmin levels in patients with chronic obstructive bronchopneumopathy]
A Lorenzo1, J J López Sáez, A Senra
1Departamento de Medicina, Facultad de Medicina, Universidad de Cádiz.
Anales De Medicina Interna (Madrid, Spain : 1984)
|March 1, 1991
Summary
Patients with chronic obstructive lung disease have higher ceruloplasmin levels. This study found no correlation with blood gas levels, suggesting an antioxidant-driven oxidation reaction.
Area of Science:
- Biochemistry
- Pulmonology
Context:
- Chronic obstructive lung disease (COPD) is a significant global health concern.
- Ceruloplasmin, a key copper-binding protein, plays roles in iron metabolism and antioxidant defense.
- Altered ceruloplasmin levels have been observed in various inflammatory and oxidative stress conditions.
Purpose:
- To investigate serum ceruloplasmin levels in patients with chronic obstructive lung disease.
- To explore potential correlations between ceruloplasmin levels and respiratory parameters in COPD patients.
Summary:
- Serum ceruloplasmin levels were significantly elevated in 20 COPD patients (51.42 +/- 11.15 mg/dl) compared to controls (36.59 +/- 13.37 mg/dl) (p < 0.005).
- No significant correlation was found between ceruloplasmin levels and partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), oxygen saturation (SaO2), or bicarbonate (HCO3-) levels.
- The findings suggest a potential oxidation reaction driven by ceruloplasmin's oxidase activity, possibly influenced by antioxidant stimuli in patients with chronic respiratory insufficiency.
Impact:
- Highlights a potential biomarker for oxidative stress in COPD.
- Suggests a link between ceruloplasmin's enzymatic activity and the pathophysiology of chronic respiratory insufficiency.
- Opens avenues for further research into the role of oxidative stress and antioxidant therapies in COPD management.